Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

PINCH in the cellular stress response to tau-hyperphosphorylation.

Ozdemir AY, Rom I, Kovalevich J, Yen W, Adiga R, Dave RS, Langford D.

PLoS One. 2013;8(3):e58232. doi: 10.1371/journal.pone.0058232. Epub 2013 Mar 12.

2.

Dysregulation of PINCH signaling in mesial temporal epilepsy.

Liu C, Russin J, Heck C, Kawata K, Adiga R, Yen W, Lambert J, Stear B, Law M, Marquez Y, Crino P, Millett D, Langford D.

J Clin Neurosci. 2017 Feb;36:43-52. doi: 10.1016/j.jocn.2016.10.012. Epub 2016 Nov 9.

PMID:
27838154
4.

Signaling via PINCH: Functions, binding partners and implications in human diseases.

Xu H, Cao H, Xiao G.

Gene. 2016 Dec 5;594(1):10-15. doi: 10.1016/j.gene.2016.08.039. Epub 2016 Aug 30. Review.

PMID:
27590440
5.

Neuronal PINCH is regulated by TNF-α and is required for neurite extension.

Jatiani A, Pannizzo P, Gualco E, Del-Valle L, Langford D.

J Neuroimmune Pharmacol. 2011 Sep;6(3):330-40. doi: 10.1007/s11481-010-9236-5. Epub 2010 Aug 6.

6.

Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.

Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, Williams DS, Goldstein LS.

J Neurosci. 2009 May 6;29(18):5758-67. doi: 10.1523/JNEUROSCI.0780-09.2009.

7.

Tau gene mutations: dissecting the pathogenesis of FTDP-17.

Ingram EM, Spillantini MG.

Trends Mol Med. 2002 Dec;8(12):555-62. Review.

PMID:
12470988
8.

Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.

Dickey CA, Yue M, Lin WL, Dickson DW, Dunmore JH, Lee WC, Zehr C, West G, Cao S, Clark AM, Caldwell GA, Caldwell KA, Eckman C, Patterson C, Hutton M, Petrucelli L.

J Neurosci. 2006 Jun 28;26(26):6985-96.

9.

Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis R, Langford D.

J Neurovirol. 2014 Aug;20(4):371-9. doi: 10.1007/s13365-014-0252-8. Epub 2014 May 10.

10.

CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Shimura H, Schwartz D, Gygi SP, Kosik KS.

J Biol Chem. 2004 Feb 6;279(6):4869-76. Epub 2003 Nov 10.

11.

Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration.

Rearden A, Hurford R, Luu N, Kieu E, Sandoval M, Perez-Liz G, Del Valle L, Powell H, Langford TD.

J Neurosci Res. 2008 Aug 15;86(11):2535-42. doi: 10.1002/jnr.21701.

PMID:
18459134
12.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
13.

CHIP-ping away at tau.

Goryunov D, Liem RK.

J Clin Invest. 2007 Mar;117(3):590-2.

14.

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.

Kumar P, Jha NK, Jha SK, Ramani K, Ambasta RK.

J Alzheimers Dis. 2015;43(2):341-61. doi: 10.3233/JAD-140933. Review.

PMID:
25096626
15.

The focal adhesion protein PINCH-1 associates with EPLIN at integrin adhesion sites.

Karaköse E, Geiger T, Flynn K, Lorenz-Baath K, Zent R, Mann M, Fässler R.

J Cell Sci. 2015 Mar 1;128(5):1023-33. doi: 10.1242/jcs.162545. Epub 2015 Jan 20.

16.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

PMID:
16987932
17.

Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis.

Donthamsetty S, Bhave VS, Mars WM, Bowen WC, Orr A, Haynes MM, Wu C, Michalopoulos GK.

PLoS One. 2013 Sep 18;8(9):e74625. doi: 10.1371/journal.pone.0074625. eCollection 2013.

18.

Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.

Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, Takashima A.

J Neurosci. 2002 Jan 1;22(1):133-41.

19.

Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes.

Saidi LJ, Polydoro M, Kay KR, Sanchez L, Mandelkow EM, Hyman BT, Spires-Jones TL.

J Alzheimers Dis. 2015;44(3):937-47. doi: 10.3233/JAD-142094.

PMID:
25374103
20.

U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.

Hatakeyama S, Matsumoto M, Kamura T, Murayama M, Chui DH, Planel E, Takahashi R, Nakayama KI, Takashima A.

J Neurochem. 2004 Oct;91(2):299-307.

Supplemental Content

Support Center